Status:
UNKNOWN
Lymphocyte Count and High Fluorescent Count (HFLC) Correlate With Liver Disorder in Dengue Fever Patients
Lead Sponsor:
Nurhasan Agung Prabowo
Conditions:
Dengue Fever
Eligibility:
All Genders
18-65 years
Brief Summary
Liver dysfunction marked by elevated alanine transaminase enzymes is quite common in dengue patients and subsequently affects the disease's severity and healing process. Unfortunately, liver function ...
Detailed Description
This cross-sectional study involves 11 dengue fever patients, consisting of 9 men and two women, at Sebelas Maret University Hospital (RS UNS), Sukoharjo. The study was conducted in May 2021. Inclusio...
Eligibility Criteria
Inclusion
- patients who were hospitalized at UNS Hospital with the following criteria: (1) adult patients (19-65 years); (2) diagnosed with dengue hemorrhagic fever according to WHO 2011 criteria; (3) routine blood examination at least once in seven days since the onset of fever; and (4) checked alanine transaminase and aspartate transaminase levels at least once in seven days from the onset of fever.
Exclusion
- \-
Key Trial Info
Start Date :
June 3 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 5 2022
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT05407181
Start Date
June 3 2022
End Date
June 5 2022
Last Update
June 7 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
RS UNS (Universitas Sebelas Maret Hospital)
Sukoharjo, Central Java, Indonesia, 57161
2
Universitas Sebelas Maret Hospital
Sukoharjo, Central Java, Indonesia, 57161